NLRX1 Inhibits LPS-Induced Microglial Death via Inducing p62-Dependent HO-1 Expression, Inhibiting MLKL and Activating PARP-1

  • Antioxidants (Basel). 2024 Apr 17;13(4):481. doi: 10.3390/antiox13040481.
Yu-Ling Huang  1 Duen-Yi Huang  1 Vladlen Klochkov  2 Chi-Ming Chan  2  3 Yuan-Shen Chen  4 Wan-Wan Lin  1  5
Affiliations
  • 1. Department of Pharmacology, College of Medicine, National Taiwan University, Taipei 100233, Taiwan.
  • 2. Department of Ophthalmology, Cardinal Tien Hospital, New Taipei City 23148, Taiwan.
  • 3. School of Medicine, Fu Jen Catholic University, New Taipei City 242062, Taiwan.
  • 4. Department of Neurosurgery, National Taiwan University, Yunlin Branch, Yunlin 640203, Taiwan.
  • 5. Graduate Institute of Medical Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Abstract

The activation of microglia and the production of cytokines are key factors contributing to progressive neurodegeneration. Despite the well-recognized neuronal programmed cell death regulated by microglial activation, the death of microglia themselves is less investigated. Nucleotide-binding oligomerization domain, leucine-rich repeat-containing X1 (NLRX1) functions as a scaffolding protein and is involved in various central nervous system diseases. In this study, we used the SM826 microglial cells to understand the role of NLRX1 in lipopolysaccharide (LPS)-induced cell death. We found LPS-induced cell death is blocked by necrostatin-1 and zVAD. Meanwhile, LPS can activate poly (ADP-ribose) polymerase-1 (PARP-1) to reduce DNA damage and induce heme oxygenase (HO)-1 expression to counteract cell death. NLRX1 silencing and PARP-1 inhibition by olaparib enhance LPS-induced SM826 microglial cell death in an additive manner. Less PARylation and higher DNA damage are observed in NLRX1-silencing cells. Moreover, LPS-induced HO-1 gene and protein expression through the p62-Keap1-Nrf2 axis are attenuated by NLRX1 silencing. In addition, the Nrf2-mediated positive feedback regulation of p62 is accordingly reduced by NLRX1 silencing. Of note, NLRX1 silencing does not affect LPS-induced cellular Reactive Oxygen Species (ROS) production but increases Mixed Lineage Kinase domain-like pseudokinase (MLKL) activation and cell Necroptosis. In addition, NLRX1 silencing blocks bafilomycin A1-induced PARP-1 activation. Taken together, for the first time, we demonstrate the role of NLRX1 in protecting microglia from LPS-induced cell death. The underlying protective mechanisms of NLRX1 include upregulating LPS-induced HO-1 expression via Nrf2-dependent p62 expression and downstream Keap1-Nrf2 axis, mediating PARP-1 activation for DNA repair via ROS- and autophagy-independent pathway, and reducing MLKL activation.

Keywords
HO-1; MLKL; NLRX1; PARP-1; microglia.
Products